Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03174990 · ClinicalTrials.gov registry record
Aspirin and Thienopyridine Resistance in Peripheral Arterial Disease
A clinical trial, sponsored by University of California, Davis.
- Completed
- Registry status
- 195
- Enrollment target
NCT03174990 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 195 participants.
The verdict
NCT03174990 has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 195 participants
- Enrollment target
Study Summary
This study evaluates the effects of Aspirin and thienopyridine resistance in relation to clinical cardiovascular outcomes as the genetic predictors of, and outcomes associated with aspirin and thienopyridine resistance in patients with peripheral arterial disease (PAD) currently remain unknown.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2010-08-31 |
| Est. Completion | 2013-12-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03174990
The ClinicalTrials.gov registry entry for NCT03174990 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 195 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03174990 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03174990 about?
NCT03174990 is a clinical study titled "Aspirin and Thienopyridine Resistance in Peripheral Arterial Disease". This study evaluates the effects of Aspirin and thienopyridine resistance in relation to clinical cardiovascular outcomes as the genetic predictors of, and outcomes associated with aspirin and thienopyridine resistance in patients with peripheral arterial disease (PAD) currently remain unknown.
What is the current status of trial NCT03174990?
This trial is currently completed. The enrollment target is 195 participants. The study started on 2010-08-31. Estimated completion is 2013-12-20.
Who is sponsoring clinical trial NCT03174990?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.